2 unknown, 1 recruiting. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Unknown 2, Recruiting 1 |
Follow Myocardial Fibrosis: new trials by email Literature Review of Myocardial Fibrosis trials Research Report on Myocardial Fibrosis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF [ARNI + SGLTi + AMR], [SGLTi + previously taken RAAS blocker] - HFpEF, LVDD | Phase 2 | Recruiting | National Medical Research Center for Cardiology, Ministry of Health of Russian Federation | 50 | 2025-03-18 | 2026-04-24 |
| Pirfenidone Treat Myocardial Fibrosis After Acute Myocardial Infarction Pirfenidone Oral Capsule, Placebo Oral Capsule - Myocardial Fibrosis | Phase 2 | Unknown | Shanghai Zhongshan Hospital | 100 | 2022-08-05 | 2022-11-10 |
| A Trial of Cardiac Injections of iMP Cells During CABG Surgery iMP cells, Control injection - Myocardial Fibrosis | Phase 2 | Unknown | Cell Therapy Ltd. | 50 | 2020-01-01 | 2020-01-27 |
Cicatrix (1) · Fibrosis (1) · Hypertrophy, Left Ventricular (1)
Pathological Conditions, Signs and Symptoms (2) · Cardiomegaly (1) · Cardiovascular Diseases (1) · Heart Diseases (1) · Hypertrophy (1) · Pathologic Processes (1) · Pathological Conditions, Anatomical (1)
pirfenidone (1)
Cell Therapy Ltd. (1) · National Medical Research Center for Cardiology, Ministry of Health of Russian Federation (1) · Shanghai Zhongshan Hospital (1)
China (1) · Russia (1)
Junbo Ge, Doctor (1) · Nigel Scott, MB BChir PhD (1)